All cell lines used in this study were purchased from American Type Culture Collection and cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Invitrogen, Carlsbad, CA). All media were supplemented with 10% fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin (Invitrogen). The A549 (RB/p53 wild-type) and H1299 cell lines (RB wild-type, p53 null) were derived from NSCLC tumors, the 5637 cell line (RB null, p53 mutant) was derived from a human bladder carcinoma, and the Saos2 cell line (RB/p53 null) was derived from a human osteosarcoma.
pCMV-SPORT6-E2F1 plasmids were used. The pGL4 vector and pGL4-DNMT3A promoter vector (promoter site, from -925 to -74) were analyzed, and the pGL4-Renilla construct was included as an internal control. For the positive control of promoter known to be regulated by RB, the empty vector (pTA-Luc) and pE2F-luciferase construct containing four repetitive E2F1-binding sites (pE2F-Luc) (purchased from Signosis, Sunnyvale, CA) were used.
Forty-eight hours after transfection, the dual luciferase reporter assay (Promega Corp., Madison, WI) was performed according to the manufacturer's protocol. Cell lysate was measured for luminescence with a Turner BioSystems luminometer (Promega). The data are presented as the means of ratio of firefly luciferase to Renilla luciferase activity from triplicate experiments.
RNA extraction, reverse-transcriptase polymerase chain reaction (RT-PCR), and quantitative RT-PCR assays
Total RNA was extracted using Trizol reagent (Invitrogen). cDNA was synthesized using SuperScript TM reverse transcriptase (Invitrogen) according to the protocols provided by the manufacturer. The primers used for RT-PCR and quantitative RT-PCR analyses are listed in Supplementary Table S3 .
To quantify the relative mRNA expression levels in the RT-PCR assay, the value of the internal standard (β-actin) in each reaction was used as the baseline gene expression of that sample and the relative value was calculated for the DNMT3A gene for cancer cells. The cycle number, amount of primers and cDNA used were determined to provide quantitative amplification during multiplex RT-PCR.
Western Blot
The cells were lysed on ice. Lysates were centrifuged at 13,000 r.p.m. for 10 min at 4°C, SDS 3 gel loading buffer was added and samples containing equal amounts of protein (50 µg) were separated on an 6% SDS-PAGE then electro-blotted onto Immobilon-P membranes (Millipore Co., Bedford, MA) in transfer buffer. Immunoblotting was performed with antibodies against DNMT3A, RB, E2F1, MDM2, Ubiquitin, and β-actin, using the conditions described in Supplementary Table S4 . Each Western analysis was repeated three times.
Immunoprecipitation (IP)
Catch and Release Reversible Immuonprecipitation System kit (Millipore Co.) was used for the analysis of protein-protein interaction. Cells were transiently transfected with empty vector or MDM2 expression vector for 24 h and treated with MG132, a 26S proteasome inhibitor, at final 6 h. Two milligram of cell lysates were incubated with the appropriate antibodies, including anti-RB or Mouse-IgG, using the conditions described in Supplementary Table S4 . After incubation at 4 o C overnight, immune complexes were washed three times with wash buffer. Proteins were eluted and then blotted with appropriate antibodies according to the manufacturer's protocol.
Chromatin immunoprecipitation (ChIP)-PCR assay
Cancer cell lysates were cross-linked with 1% formaldehyde for 15 min at 37°C and stopped Table S4 ) for 16 h at 4°C. PCR analysis for immuno-complexes of the isolated DNA fragments was performed using the primers for the DNMT3A promoters described in Supplementary Table S3 . For quantitative ChIP-PCR, total input served as internal control. Relative quantitation using the 4 comparative Ct method with the data from ABI PRISM 7000 (version 1.1 software) was performed according to the manufacturer's protocol.
DNA affinity precipitation assay (DAPA)
Two-hundred micrograms of nuclear extracts were incubated with streptavidin-agarose (Sigma-Aldrich, St. Louis, MO) for 1 h at 4°C in a head-over-head rotator, then incubated with poly(dI-dC) (Amersham, GE, Piscataway, NJ), salmon-sperm DNA, DTT, and protease inhibitor cocktail for another 1 h. Next, 5'-biotin-labeled oligonucleotides of DNMT3A
promoter and streptavidin-agarose were added and incubated for 1 h at room temperature.
Finally, oligonucleotide-bound proteins were washed five times and dissolved in SDS sample buffer and then Western blot was performed with the 5'-biotin-labeled oligonucleotides described in Supplementary Table S3 .
Quantitative methylation-specific PCR (qMSP)
The promoter methylation status of the BLU, FHIT, hRAB37, RARβ, RASSF1A, and SLIT2 genes was determined by chemical treatment with sodium bisulfite followed by qMSP analysis using a FastStar Universal SYBR Green Master (Roche Diagnostics, Mannheim, Germany). The methylation-specific primers sequences are listed in Supplementary Table   S3 . For the internal reference gene β-actin, the primers were designed to amplify and detect a region devoid of CpG nucleotides. Thus, amplification of β-actin by qMSP occurs independently of its methylation status. DNA of normal lung cell IMR90 and fully methylated IMR90 DNA treated with SssI enzyme served as positive control for both unmethylated and methylated alleles, respectively. The methylation ratio was defined as the ratio of the fluorescence signal of specific genes/β-actin to those of fully methylated IMR90
DNA/β-actin. Relative quantitation using the comparative Ct method with the data from ABI 5 PRISM 7000 (version 1.1 software) was performed according to the manufacturer's protocol.
Study population
Surgically resected tumor samples from 136 patients diagnosed with primary NSCLC admitted to Veterans General Hospital, Taichung and Taipei, were collected between 1993 and 2007 after obtaining appropriate institutional review board permission and written informed consent from the patients.
Immunohistochemistry (IHC) assay
Paraffin blocks of tumors were sectioned into 5 um slices and then processed using standard techniques. Antibodies used and their experimental conditions are provided in Supplementary Table S4 . The evaluation of the IHC staining was conducted blindly, without prior knowledge of the clinical and pathologic characteristics of the cases. The surrounding non-neoplastic stroma served as an internal negative control for each slide.
Staining was scored as +++ if >75% tumor cells were immunostaining-positive; ++ for 50-75%; + for 25-50%; +/-for 10-25% cells and -if <10% were positive. For DNMT3A or MDM2 protein expression level, the staining was graded as "overexpression" if the score were ++ and +++. For RB protein expression level, the staining was graded as "low expression" if the score was +/-or -.
Xenograft studies
Athymic nu/nu female mice (BALB/c), 4-5 weeks of age, were maintained in pathogen free conditions. The animals were implanted subcutaneously with 5 x 10 6 A549 cells in one flank per mouse The tumor size was measured according to the formula: (Length×Width 2 )/2. When tumors had attained a mass of ~50 mm 3 , animals were treated intraperitoneally with Nutlin-3 (20 mg/kg) or DMSO every other day for three weeks. Tumor samples were resected at day 25, weighed and then subjected into IHC and quantitative MSP assays.
